Published in Medical Letter on the CDC and FDA, April 4th, 2010
The resubmission includes data from three consecutive manufacturing validation batches of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA